Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F9CP6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,065
Award facts
- Contract value 100% obligated
- $29,065.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,065.25 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of November 21, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio focused on supplying medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal awards demonstrate extensive capability in fulfilling diverse pharmaceutical needs, ranging from specialty medications to generic drugs and medical devices across multiple therapeutic domains. The DLA Troop Support Medical contract represents a critical procurement vehicle enabling AmerisourceBergen to support military healthcare operations globally, with this particular delivery order contributing to the supply of immunological treatments for federal beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F9CP6?
SPE2DR26F9CP6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F9CP6 worth?
The government has obligated $29,065 on SPE2DR26F9CP6.
Is contract SPE2DR26F9CP6 an order under another contract?
Yes. SPE2DR26F9CP6 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9CP6 competed?
The extent of competition for SPE2DR26F9CP6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award